unknown
Stage
1
Investors
About
Typcal develops proprietary fungal strains to produce mycelium-based protein and fibre via biomass fermentation. Their strains are claimed to grow faster and on a wider range of feedstocks than competing technologies, aiming for scalable sustainable protein and fibre production.
Explore Typcal's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.